| Ident. | Authors (with country if any) | Title |
|---|
| 004097 (2014) |
Gerald F. Watts [Australie] ; Samuel Gidding [États-Unis] ; Anthony S. Wierzbicki [Royaume-Uni] ; Peter P. Toth [États-Unis] ; Rodrigo Alonso [Espagne] ; W. Virgil Brown [États-Unis] ; Eric Bruckert [France] ; Joep Defesche [Pays-Bas] ; KHOO KAH LIN [Malaisie] ; Michael Livingston [Royaume-Uni] ; Pedro Mata [Espagne] ; Klaus G. Parhofer [Allemagne] ; Frederick J. Raal [Afrique du Sud] ; Raul D. Santos [Brésil] ; Eric J. G. Sijbrands [Pays-Bas] ; William G. Simpson [Royaume-Uni] ; David R. Sullivan [Australie] ; Andrey V. Susekov [Russie] ; Brian Tomlinson [Hong Kong] ; Albert Wiegman [Pays-Bas] ; Shizuya Yamashita [Japon] ; John J. P. Kastelein [Pays-Bas] | Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation |
| 004187 (2014) |
Gilles Lambert [France, Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A. David Marais [Afrique du Sud] | Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects |
| 004299 (2014) |
Erik Stroes [Pays-Bas] ; David Colquhoun [Australie] ; David Sullivan [Australie] ; Fernando Civeira [Espagne] ; Robert S. Rosenson [États-Unis] ; Gerald F. Watts [Australie] ; Eric Bruckert [France] ; Leslie Cho [États-Unis] ; Ricardo Dent [États-Unis] ; Beat Knusel [États-Unis] ; Allen Xue [États-Unis] ; Rob Scott [États-Unis] ; Scott M. Wasserman [États-Unis] ; Michael Rocco [États-Unis] | Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance: The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab |
| 005883 (2012) |
Jonathan B. Johnston [États-Unis] ; Arti A. Singh [Australie] ; Anaelle A. Clary [France] ; Chiung-Kuan Chen [États-Unis] ; Patricia Y. Hayes [Australie] ; Sharon Chow [Australie] ; James J. De Voss [Australie] ; Paul R. Ortiz De Montellano [États-Unis] | Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1 |
| 006586 (2011) |
M. John Chapman [France] ; Henry N. Ginsberg [États-Unis] ; Pierre Amarenco [France] ; Felicita Andreotti [Italie] ; Jan Boren [Suède] ; Alberico L. Catapano [Italie] ; Olivier S. Descamps [Belgique] ; Edward Fisher [États-Unis] ; Petri T. Kovanen [Finlande] ; Jan Albert Kuivenhoven [Pays-Bas] ; Philippe Lesnik [France] ; Luis Masana [Espagne] ; Borge G. Nordestgaard [Danemark] ; Kausik K. Ray [Royaume-Uni] ; Zeljko Reiner [Croatie] ; Marja-Riitta Taskinen [Finlande] ; Lale Tokgözoglu [Turquie] ; Anne Tybjaerg-Hansen [Danemark] ; Gerald F. Watts [Australie] | Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management |
| 006827 (2011) |
M. John Chapman [France] | Pitavastatin: Novel effects on lipid parameters |
| 006972 (2011) |
Rachel R. Huxley [Australie, États-Unis] ; Federica Barzi [Australie] ; TAI HING LAM [Hong Kong] ; Sebastien Czernichow [Australie, France] ; XIANGHUA FANG [République populaire de Chine] ; Tim Welborn [Australie] ; Jonathan Shaw [Australie] ; Hirotsugu Ueshima [Japon] ; Paul Zimmet [Australie] ; Sun Ha Jee [Corée du Sud] ; Jeetesh V. Patel [Royaume-Uni] ; Ian Caterson [Australie] ; Vlado Perkovic [Australie] ; Mark Woodward [Australie, États-Unis] | Isolated Low Levels of High-Density Lipoprotein Cholesterol Are Associated With an Increased Risk of Coronary Heart Disease: An Individual Participant Data Meta-Analysis of 23 Studies in the Asia-Pacific Region |
| 006A28 (2011) |
YING ZHAO [Pays-Bas] ; Marieke Pennings [Pays-Bas] ; Carlos Lj. Vrins [Pays-Bas] ; Laura Calpe-Berdiel [Pays-Bas] ; Menno Hoekstra [Pays-Bas] ; J. Kar Kruijt [Pays-Bas] ; Roelof Ottenhoff [Pays-Bas] ; Reeni B. Hildebrand [Pays-Bas] ; Ronald Van Der Sluis [Pays-Bas] ; Wendy Jessup [Australie] ; Wilfried Le Goff [France] ; M. John Chapman [France] ; Thierry Huby [France] ; Albert K. Groen [Pays-Bas] ; Theo J. C. Van Berkel [Pays-Bas] ; Miranda Van Eck [Pays-Bas] | Hypocholesterolemia, foam cell accumulation, but no atherosclerosis in mice lacking ABC-transporter A1 and scavenger receptor BI |
| 007824 (2010) |
Melanie L. Hutton [Australie] ; Maria Kaparakis-Liaskos [Australie] ; Lorinda Turner [Australie] ; Ana Cardona [France] ; Terry Kwok [Australie] ; Richard L. Ferrero [Australie] | Helicobacter pylori Exploits Cholesterol-Rich Microdomains for Induction of NF-KB-Dependent Responses and Peptidoglycan Delivery in Epithelial Cells |
| 008074 (2009) |
Sandra Larrede [France] ; Carmel M. Quinn [Australie] ; Wendy Jessup [Australie] ; Eric Frisdal [France] ; Maryline Olivier [France] ; Victar Hsieh [Australie] ; Mi-Jurng Kim [Australie] ; Miranda Van Eck [Pays-Bas] ; Philippe Couvert [France] ; Alain Carrie [France] ; Philippe Giral [France] ; M. John Chapman [France] ; Maryse Guerin [France] ; Wilfried Le Goff [France] | Stimulation of Cholesterol Efflux by LXR Agonists in Cholesterol-Loaded Human Macrophages Is ABCA1-Dependent but AB CG1-Independent |
| 008206 (2009) |
Gilles Lambert [Australie, France] ; Francesca Charlton [Australie] ; Kerry-Anne Rye [Australie] ; Derek E. Piper [États-Unis] | Molecular basis of PCSK9 function |
| 008C80 (2008) |
Vivienne M. Homer [Nouvelle-Zélande] ; A. David Marais [Afrique du Sud] ; Francesca Charlton [Australie] ; Andrew D. Laurie [Nouvelle-Zélande] ; Nicola Hurndell [Nouvelle-Zélande] ; Russel Scott [Nouvelle-Zélande] ; Fabien Mangili [Australie] ; David R. Sullivan [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Peter M. George [Nouvelle-Zélande] ; Gilles Lambert [Australie, France] | Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa |
| 008E28 (2008) |
Ruud Out [Pays-Bas] ; Wendy Jessup [Australie] ; Wilfried Le Goff [France] ; Menno Hoekstra [Pays-Bas] ; Ingrid C. Gelissen [Australie] ; YING ZHAO [Pays-Bas] ; Léonard Kritharides [Australie] ; Giovanna Chimini [France] ; Johan Kuiper [Pays-Bas] ; M. John Chapman [France] ; Thierry Huby [France] ; Theo J. C. Van Berkel [Pays-Bas] ; Miranda Van Eck [Pays-Bas] | Coexistence of Foam Cells and Hypocholesterolemia in Mice Lacking the ABC Transporters Al and G1 |
| 009492 (2007) |
Evan A. Stein [États-Unis] ; John Amerena [Australie] ; Christie M. Ballantyne [États-Unis] ; Edmund Brice [Afrique du Sud] ; Michel Famier [France] ; Robert M. Guthrie [États-Unis] ; Dror Harats [Israël] ; Patrick T. S. Ma [Canada] ; Florence Le Maulf [Royaume-Uni] ; Helena Melezinkova [Royaume-Uni] ; Alex Gold [États-Unis] ; Philip Sager [États-Unis] | Long-term efficacy and safety of Rosuvastatin 40 mg in patients with severe hypercholesterolemia |
| 009615 (2007) |
Prakash Deedwania [États-Unis] ; Peter H. Stone [États-Unis] ; C. Noel Bairey Merz [États-Unis] ; Juan Cosin-Aguilar [Espagne] ; Nevres Koylan [Turquie] ; DON LUO [États-Unis] ; Pamela Ouyang [États-Unis] ; Ryszard Piotrowicz [Pologne] ; Karin Schenck-Gustafsson [Suède] ; Philippe Sellier [France] ; James H. Stein [États-Unis] ; Peter L. Thompson [Australie] ; Dan Tzivoni [Israël] | Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease : Results of the study assessing goals in the elderly (SAGE) |
| 009714 (2007) |
Robyn J. Tapp [France, Australie] ; Beverley Balkau [France] ; Jonathan E. Shaw [Australie] ; Paul Valensi [France] ; Martine Cailleau [France] ; Eveline Eschwege [France] | Association of glucose metabolism, smoking and cardiovascular risk factors with incident peripheral arterial disease : The DESIR study |
| 009B59 (2006) |
Peter Roupas [Australie] ; Peter Royle [Australie] ; Romain Descamps [France] ; Ben Scherer [Australie] ; Graeme Mcintosh [Australie] | The impact of cheese consumption on markers of cardiovascular risk in rats |
| 009C67 (2006) |
A. J. Scheen [Belgique] ; Prakash Deedwania [États-Unis] ; Philip Barter [Australie] ; Rafael Carmena [Espagne] ; Jean-Charles Fruchart [France] ; Scott M. Grundy [États-Unis] ; Steven Haffner [États-Unis] ; Jorin J. P. Kastelein [Pays-Bas] ; John C. Larosa [États-Unis] ; Holly Schachner [États-Unis] ; James Shepherd [Royaume-Uni] ; David D. Waters [États-Unis] | Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome : analysis of the Treating to New Targets study. Commentary |
| 00AC88 (2004) |
Herbert Schuster [Allemagne] ; Philip J. Barter [Australie] ; Steen Stender [Danemark] ; Raphael C. Cheung [Canada] ; Jacques Bonnet [France] ; Jonathan M. Morrell [Royaume-Uni] ; Claire Watkins [Royaume-Uni] ; David Kallend [Royaume-Uni] ; Ali Raza [Royaume-Uni] | Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study |
| 00B520 (2002) |
Laurent Meyer [France] ; Philip Bohme [France] ; Irene Delbachian [France] ; Philippe Lehert [Australie, Belgique] ; Nathalie Cugnardey [France] ; Pierre Drouin [France] ; Bruno Guerci [France] | The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients |
| 00C010 (2000) |
Jeffery L. Smith ; Paul D. Roach [Australie] ; Leonie N. Wittenberg ; Michel Riottot [France] ; S. Praga Pillay ; Paul J. Nestel [Australie] ; Les K. Nathanson | Effects of simvastatin on hepatic cholesterol metabolism, bile lithogenicity and bile acid hydrophobicity in patients with gallstones |
